AFP and hepatocellular carcinoma: A randomized controlled trial evaluating HCC surveillance through ultrasound with or without AFP, AFP-L3 and DCP has demonstrated that the association of these biomarkers with ultrasound increases sensitivity while decreasing specificity [19].